GoKawiilScience Corp's Max Hodak to preview brain-computer interface trials at TechCrunch Disrupt 2026
Science Corporation CEO Max Hodak will speak at TechCrunch Disrupt 2026's Beyond Screens session about his company's biohybrid brain-computer interface, for which it has recruited a leading neurobiologist to run the first U.S. human trials. Hodak, a Neuralink co-founder, argues that keyboards and screens will eventually give way to interfaces built directly around brain activity.
GoKawiil's interpretation of the reporting above, not reported fact.
Hodak's appearance signals that neural-interface technology is moving from speculative research toward real clinical testing and public discourse at major industry events. If successful, biohybrid interfaces could reshape how people interact with computers entirely, moving beyond input devices to direct neural communication, with major implications for accessibility, computing, and neuroscience-driven startups.
- Science Corp is preparing first U.S. human trials for its biohybrid brain-computer interface.
- Max Hodak, a Neuralink co-founder, will discuss a 'post-screen' computing future at TechCrunch Disrupt 2026.
- The event will host over 10,000 attendees focused partly on sustainable AI and emerging interface technologies.
Source: techcrunch.com — Techcrunch Events, 2026-09-16
Published there as: “Hear why Science Corp CEO Max Hodak says the screen era is ending at TechCrunch Disrupt 2026”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.